STAAB THOMAS R II

CIK 00012307084 companiesCHAPEL HILL, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001230708

Recent Transactions

50 trades

Award
TENAX THERAPEUTICS, INC.$TENX
Stock Option (right to buy)
2026-05-11+450,000→ 450,000 total
Award
TENAX THERAPEUTICS, INC.$TENX
Common Stock
2026-05-11+10,000→ 10,000 total
Tax Payment
LENSAR, Inc.$LNSR
Common Stock
2026-05-06$5.38/sh−1,350→ 174,609 total
Exercise/Conversion
LENSAR, Inc.$LNSR
Common Stock
2026-03-19$2.65/sh+5,500→ 175,959 total
Exercise/Conversion
LENSAR, Inc.$LNSR
Stock Option (Right to Buy)
2026-03-19−5,500→ 14,295 total
Tax Payment
LENSAR, Inc.$LNSR
Common Stock
2026-02-18$11.32/sh−1,076→ 170,459 total
Tax Payment
LENSAR, Inc.$LNSR
Common Stock
2026-01-11$11.57/sh−1,826→ 171,535 total
Award
LENSAR, Inc.$LNSR
Common Stock
2025-02-18+12,766→ 173,361 total
Tax Payment
LENSAR, Inc.$LNSR
Common Stock
2025-01-11$8.25/sh−1,839→ 160,595 total
Exercise/Conversion
LENSAR, Inc.$LNSR
Stock Option (Right to Buy)
2024-08-08−3,500→ 19,795 total
Exercise/Conversion
LENSAR, Inc.$LNSR
Common Stock
2024-08-08$2.65/sh+3,500→ 162,434 total
Award
LENSAR, Inc.$LNSR
Common Stock
2024-05-06+19,000→ 158,934 total
Tax Payment
LENSAR, Inc.$LNSR
Common Stock
2024-01-11$4.43/sh−1,853→ 139,934 total
Award
LENSAR, Inc.$LNSR
Common Stock
2023-01-11+6,656→ 141,787 total
Award
LENSAR, Inc.$LNSR
Stock Option (Right to Buy)
2023-01-11+23,295→ 23,295 total
Purchase
LENSAR, Inc.$LNSR
Common Stock
2022-12-07$3.16/sh+727→ 135,131 total
Purchase
LENSAR, Inc.$LNSR
Common Stock
2022-12-06$3.16/sh+2,025→ 134,404 total
Award
LENSAR, Inc.$LNSR
Stock Option (Right to Buy)
2022-01-11+52,500→ 52,500 total
Award
LENSAR, Inc.$LNSR
Common Stock
2022-01-11+15,000→ 131,409 total
Award
LENSAR, Inc.$LNSR
Stock Option (Right to Buy)
2021-04-12+49,197→ 49,197 total
Award
LENSAR, Inc.$LNSR
Common Stock
2020-12-07+19,276→ 115,657 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2020-02-21+18,000→ 18,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2020-02-14+31,500→ 31,500 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-12-17+165,000→ 165,000 total
Award
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-12-17+127,000→ 127,000 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-17$7.45/sh−2,500→ 125,176 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-16$7.72/sh−7,250→ 127,676 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-16$1.42/sh+4,750→ 134,926 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-05-16−4,750→ 61,000 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-15$7.92/sh−7,250→ 130,176 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-15$1.42/sh+4,750→ 137,426 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-05-15−4,750→ 65,750 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-14$7.62/sh−4,500→ 132,676 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-05-14−4,500→ 70,500 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-14$1.42/sh+4,500→ 137,176 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-13$5.51/sh+9,750→ 142,426 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-13$7.76/sh−9,750→ 132,676 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-05-13−9,750→ 131,250 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-09$5.51/sh+9,750→ 142,426 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-09$7.63/sh−9,750→ 132,676 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-05-09−9,750→ 141,000 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-06$5.51/sh+9,000→ 141,676 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-05-06−9,000→ 150,750 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-06$7.75/sh−9,000→ 132,676 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-02$5.51/sh+7,750→ 140,426 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-05-02$7.30/sh−7,750→ 132,676 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-05-02−7,750→ 159,750 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-04-04$5.51/sh+7,500→ 140,176 total
Sale
BIOCRYST PHARMACEUTICALS INC$BCRX
Common Stock
2019-04-04$8.81/sh−7,500→ 132,676 total
Exercise/Conversion
BIOCRYST PHARMACEUTICALS INC$BCRX
Emp. Stock Option (Right to Buy)
2019-04-04−7,500→ 167,500 total

Companies

Recent Filings

Address

101 GLEN LENNOX DRIVE SUITE 300

CHAPEL HILL, NC, 27517

View on SEC.gov